0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

RELIEF OF HYPERTENSIVE HEADACHE BY INTRAVENOUS INJECTION OF THIOCYANATE

Hubert Saint-Pierre, M.D.; A. C. Corcoran, M.D.; R. D. Taylor, M.D.; H. P. Dustan, M.D.
JAMA. 1953;152(6):493-495. doi:10.1001/jama.1953.03690060009004.
Text Size: A A A
Published online

Headache is the commonest and often the only symptom of hypertensive disease. It occurs in about 50% of patients. The distress it causes is sometimes unbearable, and the common analgesics are frequently ineffective in its relief.

Thiocyanate has long been used in the symptomatic treatment of hypertension. Because of its severe toxic effects at high serum concentration, however, periodically it lapsed into disuse until Barker1 introduced as a safeguard the technique of routine measurement of serum thiocyanate concentration. He noted relief of headache in 76% of his patients; similar incidences (from 50 to 88%) of relief have been observed by others (Kurtz, Shapiro and Mills,2 Fanson, Kinsey and Palmer,3 Blumenthal and Wetherby,4 Watkinson and Evans,5 Alstad,6 Fischman and Fischmann,7 Aas and Thingstad,8 and Thomas9). Hypertensive headache is now recognized (Page and Corcoran10) as the major indication for treatment with thiocyanate.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();